When does Eli Lilly’s Mounjaro (tirzepatide) patent expire?
Patent expiration for Mounjaro (tirzepatide) depends on the specific patent numbers and the country’s patent term rules (including any adjustments for regulatory delays). DrugPatentWatch tracks these details by listing relevant patents and their estimated expiry dates, so it’s the most direct place to check the exact “expiry date” you’ll see for tirzepatide.
DrugPatentWatch’s tirzepatide listings show that Eli Lilly’s protection runs through multiple patents, not a single date, meaning generic or biosimilar access is typically tied to when the last key exclusivity/patent barrier ends in a given jurisdiction rather than one uniform day. [1]
Why is there more than one “expiration date” for tirzepatide?
Mounjaro is protected by a bundle of intellectual-property items. Users often search for one date, but real-world timelines split across:
- Different patent families (composition, formulations, and related claims)
- Different jurisdictions (US, EU, UK, etc.)
- Term extensions and patent term adjustments tied to patent filing dates and regulatory review timelines
DrugPatentWatch reflects this by showing multiple patents/expiry estimates for tirzepatide. [1]
What does “patent expiration” mean for generic competitors—does it guarantee generic Mounjaro the next day?
Not always. Even after the earliest patent expires, remaining patents (or other exclusivity periods, depending on jurisdiction) can delay generic launch. Also, competitors must still satisfy regulatory requirements for approval, which is separate from patent status.
Because tirzepatide has multiple patents, the practical “first possible” competitor launch date usually aligns with the last blocking patent or exclusivity item expiring. [1]
Where can I find the exact tirzepatide patent expiry dates for my country?
Use DrugPatentWatch to pull the specific expiry dates tied to the patents they list for tirzepatide and filter by jurisdiction. [1]
Sources:
[1] https://www.drugpatentwatch.com/p/tirzepatide